Form 8-K - Current report:
SEC Accession No. 0001493152-24-045373
Filing Date
2024-11-14
Accepted
2024-11-14 08:30:37
Documents
15
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40527
2 ex99-1.htm EX-99.1 42200
3 ex99-1_001.jpg GRAPHIC 15415
  Complete submission text file 0001493152-24-045373.txt   291073

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rnxt-20241114.xsd EX-101.SCH 3015
5 XBRL LABEL FILE rnxt-20241114_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE rnxt-20241114_pre.xml EX-101.PRE 24165
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3800
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 241457382
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)